Opportunity Information: Apply for PAR 13 184
Apply for PAR 13 184
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Collaborative Research in Integrative Cancer Biology (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396 Cancer Biology Research.
- This funding opportunity was created on Apr 9, 2013 and posted on Apr 9, 2013.
- Applicants must submit their applications by Nov 13, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Independent school districts Native American tribal governments (Federally recognized) Private institutions of higher education State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education County governments Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity PAR 13 184, titled "Collaborative Research in Integrative Cancer Biology (U01)," supports new collaborative projects in integrative cancer biology through a cooperative agreement mechanism (U01). The central goal is to spark fresh, high-impact cancer biology research by deliberately pairing two groups: investigators who are already funded through the Integrative Cancer Biology Program (ICBP) and investigators who are not currently part of the ICBP community. The idea is that ICBP-funded teams bring established program expertise, infrastructure, data, models, and research networks, while the unaffiliated partners contribute new technologies, methods, perspectives, or specialized capabilities that expand what ICBP teams can do on their own. Projects are expected to tackle compelling cancer questions using integrative approaches, meaning they should connect multiple biological scales or data types (for example, linking molecular mechanisms to cell behavior, tissue organization, tumor evolution, microenvironment interactions, and clinical or translational relevance) rather than staying narrowly focused on a single technique or isolated pathway.
A key requirement is that the proposed work must be a true partnership between at least one ICBP-supported investigator and at least one investigator unaffiliated with ICBP. The collaboration is not optional and is not meant to be superficial; the FOA is specifically designed to bring in additional expertise, resources, or approaches that meaningfully broaden or deepen an ICBP investigator's ongoing research direction. Applications that do not involve integrative cancer biology, that do not genuinely expand an ICBP investigator's research by adding new capabilities, or that lack a real connection to existing ICBP personnel are considered out of scope and are not appropriate for this announcement. In practice, this means the proposal should clearly show why the partnership is necessary, what each party uniquely contributes, and how the combined effort will produce insights or outputs that neither side could achieve alone.
This opportunity falls under the NIH category of health-related research (CFDA 93.396, Cancer Biology Research) and does not require cost sharing or matching funds. It was posted on April 9, 2013, with the original and final closing date listed as November 13, 2015, and it was archived on December 14, 2015. Even though it is archived, the listing provides a clear snapshot of NIH's priorities at the time: building cross-team, cross-discipline collaborations to move integrative cancer biology forward, particularly by leveraging established program resources while injecting new ideas and technical strengths from outside the program.
Eligibility is broad and includes many types of domestic and international applicants. Eligible applicants include public and private institutions of higher education, nonprofits (including both 501(c)(3) and certain non-501(c)(3) organizations), for-profit organizations (including small businesses and other for-profits), and multiple levels of government (state, county, city/township, special district governments), as well as independent school districts and public housing authorities/Indian housing authorities. The eligibility language also explicitly includes a wide range of mission-driven and community-anchored organizations and institutions, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISI). Importantly, non-U.S. entities are eligible as well: foreign organizations and foreign institutions can apply, non-U.S. components of U.S. organizations are eligible, and foreign components (as defined in NIH policy) are allowed. This openness supports the FOA's underlying goal of bringing in new expertise and approaches, wherever they are located, as long as the required partnership with ICBP-funded investigators is present and the project aligns with integrative cancer biology aims.
The administering agency is the National Institutes of Health. The full announcement was available through the NIH Grants Guide (linked in the source as http://grants.nih.gov/grants/guide/pa-files/PAR-13-184.html). For access or technical issues related to the announcement, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
FAQs: NIH PAR-13-184 - Collaborative Research in Integrative Cancer Biology (U01)
What is the funding opportunity PAR-13-184?
PAR-13-184 is an NIH funding opportunity titled "Collaborative Research in Integrative Cancer Biology (U01)." It supports new collaborative projects in integrative cancer biology through a cooperative agreement mechanism (U01).
Which agency administers this opportunity?
The administering agency is the National Institutes of Health (NIH).
What is the main goal of this funding opportunity?
The central goal is to spark fresh, high-impact cancer biology research by deliberately pairing investigators already funded through the Integrative Cancer Biology Program (ICBP) with investigators who are not currently part of the ICBP community.
What kind of award mechanism is used?
This opportunity uses a cooperative agreement mechanism (U01).
What is meant by a "cooperative agreement (U01)" in this announcement?
The announcement specifies that awards are made through the U01 cooperative agreement mechanism. (No additional operational details beyond the mechanism are provided in the listing.)
What is the Integrative Cancer Biology Program (ICBP) in the context of this FOA?
In this FOA, ICBP refers to an NIH program whose funded teams bring established expertise, infrastructure, data, models, and research networks to the collaboration.
Who is expected to partner with whom?
Projects are expected to be partnerships between at least one ICBP-supported investigator and at least one investigator who is unaffiliated with ICBP.
Is collaboration optional?
No. A true collaboration is a key requirement. The FOA is specifically designed to bring in outside expertise that meaningfully broadens or deepens an ICBP investigator's research direction.
What counts as a "true partnership" under this FOA?
The collaboration is not meant to be superficial. The proposal should clearly show why the partnership is necessary, what each party uniquely contributes, and how the combined effort will produce insights or outputs that neither side could achieve alone.
What is the expected role of the ICBP-funded team in the collaboration?
ICBP-funded teams are expected to contribute established program expertise, infrastructure, data, models, and research networks.
What is the expected role of the non-ICBP (unaffiliated) partner?
The unaffiliated partner is expected to contribute new technologies, methods, perspectives, or specialized capabilities that expand what ICBP teams can do on their own.
What types of research topics are encouraged?
Projects are expected to tackle compelling cancer questions using integrative approaches, connecting multiple biological scales or data types rather than staying narrowly focused on a single technique or isolated pathway.
What does "integrative cancer biology" mean in this announcement?
Integrative approaches are described as connecting multiple biological scales or data types, such as linking molecular mechanisms to cell behavior, tissue organization, tumor evolution, microenvironment interactions, and clinical or translational relevance.
Can a proposal focused on only one pathway or single technique be appropriate?
The FOA emphasizes integrative approaches and discourages projects that remain narrowly focused on a single technique or isolated pathway rather than linking multiple scales or data types.
What makes an application out of scope for PAR-13-184?
Applications are considered out of scope if they do not involve integrative cancer biology, do not genuinely expand an ICBP investigator's research by adding new capabilities, or lack a real connection to existing ICBP personnel.
Does the project need to expand an ICBP investigator's ongoing research direction?
Yes. The FOA is designed so that the non-ICBP partner adds expertise, resources, or approaches that meaningfully broaden or deepen an ICBP investigator's ongoing research direction.
What should the application explain about each collaborator's contribution?
The proposal should clearly show what each party uniquely contributes and why the collaboration is necessary to achieve outcomes that neither side could produce alone.
What is the CFDA number and research category associated with this opportunity?
The opportunity is listed under CFDA 93.396, Cancer Biology Research, within NIH's health-related research category.
Is cost sharing or matching required?
No. The listing states that cost sharing or matching funds are not required.
When was this opportunity posted?
It was posted on April 9, 2013.
What were the closing date(s) for this opportunity?
The original and final closing date are both listed as November 13, 2015.
Is this funding opportunity still active?
No. The listing indicates it was archived on December 14, 2015.
What does it mean that the opportunity is archived?
Based on the listing, it indicates the opportunity is no longer active, but it remains as a snapshot of NIH priorities at the time, emphasizing cross-team and cross-discipline collaborations in integrative cancer biology.
Who is eligible to apply?
Eligibility is broad and includes many types of domestic and international applicants, including higher education institutions (public and private), nonprofits (including 501(c)(3) and certain non-501(c)(3)), for-profit organizations (including small businesses), and multiple levels of government.
Are U.S. state and local government entities eligible?
Yes. The eligibility language includes state governments, county governments, city or township governments, and special district governments.
Are school districts eligible?
Yes. Independent school districts are listed as eligible applicants.
Are public housing authorities eligible?
Yes. Public housing authorities and Indian housing authorities are listed as eligible applicants.
Are minority-serving institutions included in the eligible applicant types?
Yes. The eligibility language explicitly includes HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and AANAPISI institutions.
Can for-profit organizations apply?
Yes. For-profit organizations, including small businesses and other for-profits, are listed as eligible applicants.
Can nonprofit organizations apply?
Yes. Nonprofits are eligible, including 501(c)(3) organizations and certain non-501(c)(3) organizations.
Are foreign (non-U.S.) organizations eligible to apply?
Yes. The listing states that foreign organizations and foreign institutions can apply.
Are non-U.S. components of U.S. organizations eligible?
Yes. Non-U.S. components of U.S. organizations are listed as eligible.
Are foreign components allowed under NIH policy for this opportunity?
Yes. The listing states that foreign components (as defined in NIH policy) are allowed.
Does broad organizational eligibility remove the requirement to partner with ICBP investigators?
No. Regardless of organizational eligibility, the FOA requires a true partnership between at least one ICBP-supported investigator and at least one investigator unaffiliated with ICBP.
Where can applicants find the full NIH announcement?
The full announcement was available through the NIH Grants Guide at: http://grants.nih.gov/grants/guide/pa-files/PAR-13-184.html
Who is the contact for access or technical issues related to the announcement?
The contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: PPHF 2013 Cooperative Agreement to Support Navigators in Federally facilitated and State Partnership Exchanges
Previous opportunity: Diligent Recruitment of Families for Children in the Foster Care System
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 184
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 184) also looked into and applied for these:
| Funding Opportunity |
|---|
| Image guided Drug Delivery in Cancer (R01) Apply for PAR 13 185 Funding Number: PAR 13 185 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R01) Apply for RFA MH 14 170 Funding Number: RFA MH 14 170 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R21) Apply for RFA MH 14 171 Funding Number: RFA MH 14 171 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Detection of Pathogen Induced Cancer (DPIC) (R01) Apply for PAR 13 190 Funding Number: PAR 13 190 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revision Applications to U01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (U01) Apply for PAR 13 176 Funding Number: PAR 13 176 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Imaging and Biomarkers for Early Cancer Detection (R01) Apply for PAR 13 189 Funding Number: PAR 13 189 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revision Applications to R01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (R01) Apply for PAR 13 177 Funding Number: PAR 13 177 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50) Apply for PAR 13 174 Funding Number: PAR 13 174 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to R01 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (R01) Apply for PAR 13 172 Funding Number: PAR 13 172 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to U01 Awards on Detection of Pathogen Induced Cancer (DPIC) (U01) Apply for PAR 13 173 Funding Number: PAR 13 173 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01) Apply for PAR 13 175 Funding Number: PAR 13 175 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions to P50 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P50) Apply for PAR 13 170 Funding Number: PAR 13 170 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions to P01 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P01) Apply for PAR 13 171 Funding Number: PAR 13 171 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Paul Calabresi Career Development Award for Clinical Oncology (K12) Apply for PAR 13 201 Funding Number: PAR 13 201 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Symptom Management in HIV Infected Individuals with Comorbid Conditions (R01) Apply for PA 13 210 Funding Number: PA 13 210 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Symptom Management in HIV Infected Individuals with Comorbid Conditions (R21) Apply for PA 13 211 Funding Number: PA 13 211 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Innovative Measurement Tools for Community Engaged Research Efforts (R01) Apply for PA 13 209 Funding Number: PA 13 209 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Measurement Tools for Community Engaged Research Efforts (R21) Apply for PA 13 212 Funding Number: PA 13 212 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Fogarty HIV Research Training Program for Low and Middle Income Country Institutions (D43) Apply for PAR 13 126 Funding Number: PAR 13 126 Agency: National Institutes of Health Category: Education Health Funding Amount: $282,000 |
| Medications Development Centers of Excellence Cooperative Program (U54) Apply for RFA DA 14 004 Funding Number: RFA DA 14 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 184", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.